CellaVision AB (publ)

Total Valuation

CellaVision AB (publ) carries a market capitalization of 3.42B, placing it among publicly traded companies globally. Its enterprise value stands at 3.46B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

CellaVision AB (publ) currently has 23.85M shares outstanding.

Valuation Ratios

CellaVision AB (publ) trades at a trailing price-to-earnings ratio of 27.33.

Enterprise Valuation

On an enterprise value basis, CellaVision AB (publ) trades at an EV/EBITDA multiple of 19.92 and an EV/FCF ratio of 16.76. The EV/Sales ratio of 4.73 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 19.92 provides insight into valuation relative to core operating earnings.

Financial Position

CellaVision AB (publ) maintains a current ratio of 3.80, meaning it holds 3.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.45, indicating elevated leverage, while an interest coverage ratio of 29.18 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, CellaVision AB (publ) has paid 36.18M in income taxes, reflecting an effective tax rate of 21.25.

Stock Price Statistics

CellaVision AB (publ)'s stock has declined approximately -20.77348% over the past 52 weeks. The 50-day moving average sits at 127.92, while the 200-day moving average is 151.30.

Income Statement

Over the trailing twelve months, CellaVision AB (publ) generated 730.59M in revenue and converted that into 134.07M in net income, yielding earnings per share of 5.62. EBITDA reached 173.45M, while operating income came in at 173.45M.

Balance Sheet

CellaVision AB (publ) holds 230.22M in cash and equivalents against 22.43M in total debt, resulting in a net debt position of -207.79M.

Cash Flow

CellaVision AB (publ) produced 201.54M in operating cash flow over the past twelve months.

Margins

CellaVision AB (publ) operates with a gross margin of 67.98, reflecting its pricing power and cost economics. The operating margin of 23.74 and net profit margin of 18.35 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 44.48 indicates the proportion of earnings distributed to shareholders.

Scores

CellaVision AB (publ) posts an Altman Z-Score of 12.85, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.